You just read:

Innovent Biologics Announces FDA Approval of Pemazyre™ (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma

News provided by

Innovent Biologics, Inc.

Apr 19, 2020, 20:00 ET